Neurology®
The most widely read and highly cited peer-reviewed Neurology journal
Quick Search
Advanced Search
Published online before print April 9, 2008, doi:10.1212/01.wnl.0000289190.66955.67)
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
01.wnl.0000289190.66955.67v1
70/20/1876    most recent
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ørngreen, M. C.
Right arrow Articles by Vissing, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ørngreen, M. C.
Right arrow Articles by Vissing, J.
NEUROLOGY 2008;70:1876-1882
© 2008 American Academy of Neurology

Is muscle glycogenolysis impaired in X-linked phosphorylase b kinase deficiency?

M. C. Ørngreen, MD, H. J. Schelhaas, MD, PhD, T. D. Jeppesen, MD, H. O. Akman, PhD, R. A. Wevers, PhD, S. T. Andersen, MD, H. J. ter Laak, PhD, O. P. van Diggelen, PhD, S. DiMauro, MD and J. Vissing, MD, PhD

From the Neuromuscular Research Unit (M.C.O., T.D.J., S.T.A., J.V.), Department of Neurology, and the Copenhagen Muscle Research Center, Copenhagen, Denmark; Neuromuscular Center (H.J.S., R.A.W., H.J.t.L.), Department of Neurology, University Medical Center Nijmegen, the Netherlands; Department of Neurology (H.O.A., S.D.), Columbia University Medical Center, New York, NY; and Department of Clinical Genetics (O.P.v.D.), Erasmus University Medical Centre, Rotterdam, the Netherlands.

Address correspondence and reprint requests to Dr. Mette Cathrine Ørngreen, Neuromuscular Research Unit 7611, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, DK-2100 Copenhagen, Denmark rh10679{at}rh.dk

Objective: It is unclear to what extent muscle phosphorylase b kinase (PHK) deficiency is associated with exercise-related symptoms and impaired muscle metabolism, because 1) only four patients have been characterized at the molecular level, 2) reported symptoms have been nonspecific, and 3) lactate responses to ischemic handgrip exercise have been normal.

Methods: We studied a 50-year-old man with X-linked PHK deficiency using ischemic forearm and cycle ergometry exercise tests to define the derangement of muscle metabolism. We compared our findings with those in patients with McArdle disease and in healthy subjects.

Results: Sequencing of PHKA1 showed a novel pathogenic mutation (c.831G>A) in exon 7. There was a normal increase of plasma lactate during forearm ischemic exercise, but lactate did not change during dynamic, submaximal exercise in contrast to the fourfold increase in healthy subjects. Constant workload elicited a second wind in all patients with McArdle disease, but not in the patient with PHK deficiency. IV glucose administration appeared to improve exercise tolerance in the patient with PHK deficiency, but not to the same extent as in the patients with McArdle disease. Lipolysis was higher in the patient with PHK deficiency than in controls.

Conclusion: These findings demonstrate that X-linked PHK deficiency causes a mild metabolic myopathy with blunted muscle glycogen breakdown and impaired lactate production during dynamic exercise, which impairs oxidative capacity only marginally. The different response of lactate to submaximal and maximal exercise is likely related to differential activation mechanisms for myophosphorylase.

Abbreviations: GSD = glycogen storage disease; PHK = phosphorylase b kinase; RER = respiratory exchange rate.


Supplemental data at www.neurology.org

Editorial, page 1872

e-Pub ahead of print on April 9, 2008, at www.neurology.org.

Disclosure: The authors report no conflicts of interest.

Received May 9, 2007. Accepted in final form August 28, 2007.




This article has been cited by other articles:


Home page
NEJMHome page
T. Stojkovic, J. Vissing, F. Petit, M. Piraud, M. C. Orngreen, G. Andersen, K. G. Claeys, C. Wary, J.-Y. Hogrel, and P. Laforet
Muscle Glycogenosis Due to Phosphoglucomutase 1 Deficiency
N. Engl. J. Med., July 23, 2009; 361(4): 425 - 427.
[Full Text] [PDF]


Home page
BrainHome page
J. Vissing, M. Duno, M. Schwartz, and R. G. Haller
Splice mutations preserve myophosphorylase activity that ameliorates the phenotype in McArdle disease
Brain, June 1, 2009; 132(6): 1545 - 1552.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
R. G. Haller
Fueling around with glycogen: The implications of muscle phosphorylase b kinase deficiency
Neurology, May 13, 2008; 70(20): 1872 - 1873.
[Full Text] [PDF]